Skip to content

Multiinsitutional prospective observational study of Radiotherapy for metastatis bone tumor

Multiinsitutional prospective observational study of Radiotherapy for metastatis bone tumor - Multiinsitutional prospective observational study of Radiotherapy for metastatis bone tumor

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000042491
Enrollment
280
Registered
2020-12-01
Start date
2020-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic bone tumor

Interventions

None listed

Sponsors

Shizuoka Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Radiotherapy for bone metastasis is planned Written informed consent

Exclusion criteria

Exclusion criteria: Inappropriate for study participation by the treating physician

Design outcomes

Primary

MeasureTime frame
1)type of cancer, treatment policy, irradiation method

Secondary

MeasureTime frame
2)pain response, skeletal related event 3)Toxicity 4)Quality of life,employment status

Countries

Japan

Contacts

Public ContactHideyuki Harada

Shizuoka Cancer Center Radiation and Proton Therapy Center

h.harada@scchr.jp0559895222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026